The Provincial Laboratory Medicine Services (PLMS) discipline of hematopathology stewards the development and delivery of hematopathology services in British Columbia.
We achieve this by collaborating with PLMS, the health authorities, private laboratory partners, and the Ministry of Health.
The committee provides expert advice within the context of provincial acute- and community-based service delivery. The committee takes into account safety, appropriateness, effectiveness, legal, social, ethical, and workflow/service delivery impacts as well as the priorities of PLMS, the health authorities, and the Ministry of Health.
The committee:
- Creates a work plan that aligns with and supports the implementation of the PLMS Strategic Service Delivery Plan/Roadmap.
- Reviews, evaluates, and makes evidence-based assessments for test and/or guideline inclusion, removal, modification or replacement; taking into consideration Guideline and Protocols Advisory Committee (GPAC) priorities, environmental impact and the Choosing Labs Wisely initiative as appropriate.
- Reviews relevant laboratory-related guidelines and provides feedback on their clinical and operational impact on laboratories.
- Receives and responds to specific requests for test review/assessment using stringent evaluation criteria and expert consultation. Advises on the medical necessity (clinical validity and utility) of the test, the analytical validity, and service delivery model options that take into consideration expected volumes and the distribution of patients within B.C. (i.e. centralized/de-centralized).
- Provides advice on urgent clinical, technical, operational ,and quality assurance needs.
- Identifies and fosters discussions on operational and technical quality improvement, utilization/stewardship, environmental sustainability, optimization, and innovation opportunities within the discipline of hematopathology to ensure a coordinated provincial delivery approach.
- Performs environmental scans of the evolving nature of testing, its impact on patient care, and the interests of multiple stakeholders.
- Provides advice for appropriate testing platforms and technology within the discipline of hematopathology.
- Acts as ambassadors to increase awareness of PLMS.
- Dr. Nadia Medvedev, Medical Lead and chair
- Lorraine Liu, Strategic Lead and co-chair
- Dr. Danielle Meunier, VIHA
- Dr. Annemarie De Koker, VIHA (alternate)
- Dr. Sophia Peng, VIHA (alternate)
- Dr. Nicholas Au, CW
- Dr. Kate Chipperfield, CW (alternate)
- Dr. Bhupinder Johal, IHA
- Dr. Nick Sunderland, IHA
- Dr. Denis Bonin, IHA (alternate)
- Dr. Miranda Wozniak, Dynacare
- Dr. Jason Doyle, Dynacare (alternate)
- Dr. Justin Lo, NHA
- Dr. Hamish Nicolson, PHC
- Dr. Rodrigo Onell, PHC (alternate)
- Dr. Mohammad Bahmanyar, PHC (alternate)
- Dr. Ann Tran, PHC (alternate)
- Dr. Kristine Roland, VCH
- Dr Ayesha Vawda, LifeLabs
- Dr. Peter Van den Elzen, LifeLabs (alternate)
- Dr. Wilson Yeung, FHA
- Dr. Youness Elkhalidy, FHA (alternate)
- Ladan Maclucas, VIHA
- Mishelle Petrusa, VIHA (alternate)
- Corinne Patterson, CW
- Mykola Maydan, CW (alternate)
- Tammy Kirbyson, IHA
- Trisha Elliot, IHA (alternate)
- Candice Burston, Dynacare
- Jennifer Gagnon, NHA
- Gurjit Bubra, PHC
- Steven Wong, PHC (alternate)
- Jim Yakimec, VCH
- Geoffrey Chan, VCH (alternate)
- Rhonda Cresswell, LIfeLabs
- Jane Howsham, FHA
- Makhan Rana, BCCA
- Catriona Gano, PLMS
- Tania Johnson, Ministry of Health
For questions about the advisory committee, please email
nadejda.medvedev@vch.ca or lorraine.liu@phsa.ca.
Newsletters
